UN Office Of Drugs And Crime Enters Debate Over Fake Medicines And IP

counterfeit meds

The Vienna-based United Nations Office on Drugs and Crime (UNODC) has been working for several years to fight “fraudulent” medicines in the global supply chain. But an alleged new draft model legislation it is developing includes intellectual property rights, an issue which has led to intensive debates in other international fora. This week, a closed-door UNODC informal expert group drafting the model legislation is meeting in Vienna.

Index: Pharma Industry Improves On Access To Medicines, Needs Work On Ethics, Patent Disclosure

2014 Access to Medicine Index image

The 2014 edition of an independent ranking of leading pharmaceutical companies’ efforts to help developing countries released today found new initiatives undertaken in the past two years. But it said corruption and insufficient disclosure of existing patents continue to plague the industry.

WHO Influenza Preparedness Report Shows Companies Not Fulfilling Obligations

Influenza Virus - Flickr - Sanofi Pasteur

The World Health Organization Pandemic Influenza Preparedness (PIP) Framework is at risk due to some companies not fulfilling their obligations, a new WHO report says.

WHO In Race To Find Promising Ebola Treatments As Many Products Ruled Out

Ebola virus - Flickr CDC Global

Proposals for products to help fight Ebola are coming in to the World Health Organization, but few look promising so far, an official said today. Meanwhile, efforts are on to establish testing sites for potential products, and thinking is still in the early stages on intellectual property rights for new drugs in development.

Expect Strong IP Push From Global Pharma Industry Next Year; WHO Prescribes Dose Of Reality

Medicines - FLickr - Nina Matthews

NEW YORK – Strong intellectual property rights will be a top priority for the pharmaceutical industry internationally in the coming year and arguments over IPRs versus medicines access are false, a top representative said at a high-level industry event this week. But views at the event differed on expectations of industry in light of the Ebola crisis, hepatitis C drug costs or other medicines access questions.

WTO, WHO, WIPO Examine IPRs And Middle-Income Countries

Health - Flickr - 401KCalculator.org

The current income-based grouping of countries needs to be changed or access to medicines in middle-income countries will worsen, several speakers said yesterday at a joint meeting between three international organisations on health, trade, and intellectual property. But middle-income countries should step up their engagement in organisations such as the World Health Organization, according to WHO and civil society.

WHO Ebola Vaccine Meeting Draws Commitment From Pharma, Donors; MSF Sees Need For Concrete Actions

Ebola Vaccine - Flickr - NIAID

A high-level meeting convened by the World Health Organization yesterday on the issue of access to and financing of Ebola vaccines resulted in a set of commitments, though not with sufficient urgency for those working on the ground. The pharmaceutical industry committed to scale up production, while donors pledged funds without disclosing how deep their pockets might be.

Life Sciences Stakeholders Assess Accessing Emerging Markets

Conference emerging-market-access Oct 2014

PARIS –Life sciences stakeholders at a recent conference explored matters associated with market access in the BRICS (Brazil, Russia, India, China, South Africa) and in the Middle East and North Africa regions.

WTO Director General Presents TRIPS As Major Tool For Trade Growth

Azevedo Federal Bar Asso - Oct 2014 - WTO

World Trade Organization Director General Roberto Azevêdo this week hailed WTO’s intellectual property agreement, saying the past two decades show it provides a balanced multilateral foundation for the growth of trade in knowledge-rich products and services.